Episode 098: Understanding MRD Testing in CLL
The Fellow on Call: The Heme/Onc Podcast
00:00
Understanding MRD Testing in CLL
This chapter explores the complexities of minimal residual disease (MRD) testing in chronic lymphocytic leukemia (CLL), comparing detection sensitivity in bone marrow and peripheral blood and the influence of treatment regimens on patient outcomes. It highlights ongoing research into the clinical significance of MRD negativity and the implications for treatment strategies, particularly with therapies like obinutuzumab and venetoclax.
Transcript
Play full episode
